(Q48213465)

9 February 2018

title

A New Orphan Receptor Involved in Pulsatile Growth Hormone Release (English)

1 reference

9 February 2018

author name string

Smith RG

1

1 reference

9 February 2018

Feighner S

2

1 reference

9 February 2018

Prendergast K

3

1 reference

9 February 2018

Guan X

4

1 reference

9 February 2018

Howard A

5

1 reference

9 February 2018

publication date

1 May 1999

1 reference

9 February 2018

Trends in Endocrinology and Metabolism

published in

1 reference

9 February 2018

volume

10

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

128-135

1 reference

9 February 2018

Design, Synthesis, and Biological Activity of Peptides which Release Growth Hormone in Vitro*

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

A nonpeptidyl growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Peptidomimetic growth hormone secretagogues. Design considerations and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

A potent, orally bioavailable benzazepinone growth hormone secretagogue.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Identification of a new G-protein-linked receptor for growth hormone secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

GHRP-6 induces a biphasic calcium response in rat pituitary somatotrophs

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Peptidomimetic regulation of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Induction of c-fos Messenger Ribonucleic Acid in Neuropeptide Y and Growth Hormone (GH)-Releasing Factor Neurons in the Rat Arcuate Nucleus Following Systemic Injection of the GH Secretagogue, GH-Releasing Peptide-6

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Endogenous growth hormone (GH) secretion in male rats is synchronized to pulsatile GH infusions given at 3-hour intervals

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Central administration of a growth hormone (GH) receptor mRNA antisense increases GH pulsatility and decreases hypothalamic somatostatin expression in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900132-5

7 January 2021

10.1016/S1043-2760(98)00132-5

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018